Literature DB >> 14870946

Death and dependence: current controversies over the selective serotonin reuptake inhibitors.

David J Nutt1.   

Abstract

Recent years have seen a considerable media interest in the adverse effects of the selective serotonin reuptake inhibitors (SSRIs). This has led to claims that these antidepressants may lead to suicide and homicide and that they cause dependence or even addiction. Such claims have caused great concerns to many patients and have confused doctors in both primary care and psychiatric practice. In this article I review the basis of these claims and show that many seem to emerge from the misinterpretation of evidence and the use of imprecise definitions. Although the SSRIs are not free of problems they compare very favourably with other antidepressants and other classes of psychotropic drugs. There is no evidence they are addictive in the formal sense of leading to a drug dependence syndrome. Some suggestions on the way these issues can be more precisely defined and studied in future are given.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14870946     DOI: 10.1177/0269881103174019

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  10 in total

Review 1.  Antidepressants and suicide: what is the balance of benefit and harm.

Authors:  David Gunnell; Deborah Ashby
Journal:  BMJ       Date:  2004-07-03

2.  Antidepressants and suicide: risk of completed suicide is not the same as risk of deliberate self harm.

Authors:  Alex J Mitchell
Journal:  BMJ       Date:  2004-08-21

Review 3.  Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.

Authors:  Hans-Jürgen Möller; David S Baldwin; Guy Goodwin; Siegfried Kasper; Ahmed Okasha; Dan J Stein; Rajiv Tandon; Marcio Versiani
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-08       Impact factor: 5.270

4.  Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review.

Authors:  David Gunnell; Julia Saperia; Deborah Ashby
Journal:  BMJ       Date:  2005-02-19

Review 5.  Suicidal ideation during antidepressant treatment: do genetic predictors exist?

Authors:  Nader Perroud
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

Review 6.  Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-01       Impact factor: 5.270

7.  Time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey.

Authors:  George M Anderson; Christina S Barr; Stephen Lindell; Amy C Durham; Ilya Shifrovich; J Dee Higley
Journal:  Psychopharmacology (Berl)       Date:  2004-09-25       Impact factor: 4.530

Review 8.  Self harm and attempted suicide in adults: 10 practical questions and answers for emergency department staff.

Authors:  A J Mitchell; M Dennis
Journal:  Emerg Med J       Date:  2006-04       Impact factor: 2.740

9.  Antidepressants, withdrawal, and addiction; where are we now?

Authors:  Sameer Jauhar; Joseph Hayes; Guy M Goodwin; David S Baldwin; Philip J Cowen; David J Nutt
Journal:  J Psychopharmacol       Date:  2019-05-21       Impact factor: 4.562

Review 10.  Cannabis based medicines and cannabis dependence: A critical review of issues and evidence.

Authors:  Anne K Schlag; Chandni Hindocha; Rayyan Zafar; David J Nutt; H Valerie Curran
Journal:  J Psychopharmacol       Date:  2021-02-17       Impact factor: 4.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.